Cervical Cancer clinical trials in New Hampshire

5 actively recruiting cervical cancer trials at 3 sites across New Hampshire.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting NIH

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT06568172

Sites in New Hampshire:

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center — Lebanon, New Hampshire

View on ClinicalTrials.gov →

Phase 3 Recruiting NIH

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

This phase III trial compares the effect of adding cetuximab to pembrolizumab versus pembrolizumab alone in treating patients with head and neck squamous cell carcinoma (HNSCC) that has come back after a period of improvement (recurrent) a…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT06589804

Sites in New Hampshire:

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center — Lebanon, New Hampshire

View on ClinicalTrials.gov →

Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05334069

Sites in New Hampshire:

New Hampshire Oncology Hematology PA-Concord — Concord, New Hampshire
Solinsky Center for Cancer Care — Manchester, New Hampshire

View on ClinicalTrials.gov →

NA Recruiting Academic/Other

TRAIL Study: Feasibility and Pilot

This is a pilot study to compare two ways of managing newly identified thyroid nodules that are likely to be cancerous based on ultrasound result and which under usual care would undergo immediate biopsy. The main goals of this pilot study…

Sponsor: Dartmouth-Hitchcock Medical Center

NCT ID: NCT06220656

Sites in New Hampshire:

Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire

View on ClinicalTrials.gov →

NA Recruiting Academic/Other

Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer

This is a single-arm clinical trial to evaluate the feasibility of a chemotherapy regimen using adaptive, individualized dose escalation of 5-FU chemotherapy for patients who have good tolerance of the initial dose. Study participants will…

Sponsor: Dartmouth-Hitchcock Medical Center

NCT ID: NCT05780684

Sites in New Hampshire:

Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20